Thyroid function tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 9: | Line 9: | ||
TFTs may be requested if a patient is thought to suffer from [[hyperthyroidism]] (overactive thyroid) or [[hypothyroidism]] (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as [[atrial fibrillation]]. | TFTs may be requested if a patient is thought to suffer from [[hyperthyroidism]] (overactive thyroid) or [[hypothyroidism]] (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as [[atrial fibrillation]]. | ||
[[Category:Chemical pathology]] | [[Category:Chemical pathology]] |
Revision as of 16:55, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Thyroid function tests (TFTs) is a collective term for blood tests used to check the function of the thyroid.
A TFT panel typically includes thyroid-stimulating hormone (TSH, thyrotropin) and thyroxine (T4), and triiodothyronine (T3) depending on local laboratory policy.
TFTs may be requested if a patient is thought to suffer from hyperthyroidism (overactive thyroid) or hypothyroidism (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as atrial fibrillation.